Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Research Cooperation Technologies
Tucson, Arizona, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
RCT itself does not develop therapeutics directly, but it has enabled commercialization of important pharmaceuticals (cisplatin, carboplatin, Vimpat), diagnostics (PSA blood test), and life science platforms (ClearColi). Clinical results for these programs are with their downstream licensees/partners[2].
- Therapeutic areas
- OncologyNeurologyOther
- Modalities
- Small moleculeProteinRecombinant proteinBiologic
- Industry
- Investors
02
Partnerships
Lucigen (distribution and licensing partner for ClearColi Expression Technology)Start-Up AustraliaMajor collaborations with researchers and universities worldwide
Beyond the preview
Go deeper on Research Cooperation Technologies.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Research Cooperation Technologies.